For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel ...

Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as much weight as an Eli Lilly product.

Novo shares slump after the Danish drugmaker’s experimental obesity drug fails to beat Lilly’s treatment in an 84-week trial.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these ...

The idea is that the body exhausts the calories consumed through food and then relies on fat stores, reducing weight through ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

“I want the weight off and it’s coming off!” the Grammy winner said ...

Serena Williams is embracing her new physique and proudly putting it on display for fans. The retired tennis icon, who ...